Frequently Asked Questions
The market is segmented based on , By Type (Branded, Generic), Therapy Area (Oncology, Immunology, Ophthalmology, Respiratory, Dermatology, Gastroenterology, Urology, Gynaecology, Endocrinology, Others), Route of Administration (Oral, Topical, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2031.
.
The Global Prescription Drugs Market size was valued at USD 1035.50 USD Billion in 2022.
The Global Prescription Drugs Market is projected to grow at a CAGR of 9% during the forecast period of 2023 to 2030.
The major players operating in the market include F. Hoffmann, La Roche , Mylan N.V., Teva Pharmaceutical Industries , Sanofi, Pfizer , GlaxoSmithKline plc, Novartis AG, Merck & Co. , Allergan, AstraZeneca, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Bristol Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH, Dr. 'Reddy's Laboratories , Gilead Sciences , Amgen , Eli Lilly and Company, AbbVie , Lupin..
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
